Annual Working Capital
-$913.80 K
-$2.85 M-147.24%
December 1, 2024
Summary
- As of March 10, 2025, VRPX annual working capital is -$913.80 thousand, with the most recent change of -$2.85 million (-147.24%) on December 1, 2024.
- During the last 3 years, VRPX annual working capital has fallen by -$38.40 million (-102.44%).
- VRPX annual working capital is now -102.44% below its all-time high of $37.48 million, reached on December 31, 2021.
Performance
VRPX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$913.80 K
+$1.14 M+55.46%
December 1, 2024
Summary
- As of March 10, 2025, VRPX quarterly working capital is -$913.80 thousand, with the most recent change of +$1.14 million (+55.46%) on December 1, 2024.
- Over the past year, VRPX quarterly working capital has stayed the same.
- VRPX quarterly working capital is now -102.20% below its all-time high of $41.46 million, reached on September 30, 2021.
Performance
VRPX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
VRPX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -147.2% | 0.0% |
| 3 y3 years | -102.4% | -102.4% |
| 5 y5 years | +66.6% | -102.2% |
VRPX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -102.4% | at low | -102.4% | +67.3% |
| 5 y | 5-year | -102.4% | +74.5% | -102.2% | +74.5% |
| alltime | all time | -102.4% | +74.5% | -102.2% | +74.5% |
Virpax Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$913.80 K(-147.2%) | -$913.80 K(-55.5%) |
| Sep 2024 | - | -$2.05 M(-26.6%) |
| Jun 2024 | - | -$2.79 M(+130.3%) |
| Mar 2024 | - | -$1.21 M(-162.7%) |
| Dec 2023 | $1.93 M(-88.3%) | $1.93 M(-70.3%) |
| Sep 2023 | - | $6.51 M(-47.1%) |
| Jun 2023 | - | $12.30 M(-19.0%) |
| Mar 2023 | - | $15.20 M(-8.3%) |
| Dec 2022 | $16.58 M | $16.58 M(-14.7%) |
| Sep 2022 | - | $19.43 M(-27.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $26.92 M(-17.3%) |
| Mar 2022 | - | $32.56 M(-13.1%) |
| Dec 2021 | $37.48 M(-1145.1%) | $37.48 M(-9.6%) |
| Sep 2021 | - | $41.46 M(+384.5%) |
| Jun 2021 | - | $8.56 M(-19.1%) |
| Mar 2021 | - | $10.58 M(-395.0%) |
| Dec 2020 | -$3.59 M(+31.3%) | -$3.59 M(+19.9%) |
| Sep 2020 | - | -$2.99 M(+9.5%) |
| Dec 2019 | -$2.73 M(+129.1%) | -$2.73 M |
| Dec 2018 | -$1.19 M | - |
FAQ
- What is Virpax Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals annual working capital year-on-year change?
- What is Virpax Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly working capital year-on-year change?
What is Virpax Pharmaceuticals annual working capital?
The current annual working capital of VRPX is -$913.80 K
What is the all time high annual working capital for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual working capital is $37.48 M
What is Virpax Pharmaceuticals annual working capital year-on-year change?
Over the past year, VRPX annual working capital has changed by -$2.85 M (-147.24%)
What is Virpax Pharmaceuticals quarterly working capital?
The current quarterly working capital of VRPX is -$913.80 K
What is the all time high quarterly working capital for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly working capital is $41.46 M
What is Virpax Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, VRPX quarterly working capital has changed by $0.00 (0.00%)